Aspire Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$443K Hold
1,374
0.24% 69
2024
Q2
$429K Hold
1,374
0.25% 68
2024
Q1
$391K Hold
1,374
0.24% 69
2023
Q4
$396K Hold
1,374
0.27% 62
2023
Q3
$369K Hold
1,374
0.28% 59
2023
Q2
$305K Sell
1,374
-10
-0.7% -$2.32K 0.23% 63
2023
Q1
$335K Hold
1,384
0.27% 63
2022
Q4
$363K Sell
1,384
-40
-3% -$10.7K 0.32% 55
2022
Q3
$321K Hold
1,424
0.3% 59
2022
Q2
$346K Hold
1,424
0.32% 59
2022
Q1
$344K Buy
1,424
+10
+0.7% +$2.3K 0.27% 61
2021
Q4
$318K Buy
+1,414
New +$298K 0.26% 63

Other funds holding AMGN

Aspire Wealth Management's AMGN Position: Q3 2024 in Review

Aspire Wealth Management held its Amgen (AMGN) position steady in Q3 2024 at 1,374 shares worth $443K. The position accounts for 0.24% of the portfolio, ranked #69.

Aspire Wealth Management first reported a position in AMGN in Q4 2021 and has held it in 12 quarters since. 2,823 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

  • Aspire Wealth Management held 1,374 shares of Amgen worth $443K as of Q3 2024.
  • Aspire Wealth Management left its Amgen share count unchanged in Q3 2024.
  • Amgen made up 0.24% of Aspire Wealth Management's portfolio in Q3 2024, its #69 holding.
  • Aspire Wealth Management first reported a position in Amgen in Q4 2021 and has held it in 12 quarters since.
  • 2,823 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on Aspire Wealth Management's 13F filing for Q3 2024, filed 31 Oct 2024.